214 related articles for article (PubMed ID: 35509981)
61. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
62. The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma.
Li X; Dai Z; Wu X; Zhang N; Zhang H; Wang Z; Zhang X; Liang X; Luo P; Zhang J; Liu Z; Zhou Y; Cheng Q; Chang R
Front Immunol; 2022; 13():749241. PubMed ID: 35529878
[TBL] [Abstract][Full Text] [Related]
63. Expression levels and co‑targets of miRNA‑126‑3p and miRNA‑126‑5p in lung adenocarcinoma tissues: Αn exploration with RT‑qPCR, microarray and bioinformatic analyses.
Chen P; Gu YY; Ma FC; He RQ; Li ZY; Zhai GQ; Lin X; Hu XH; Pan LJ; Chen G
Oncol Rep; 2019 Feb; 41(2):939-953. PubMed ID: 30535503
[TBL] [Abstract][Full Text] [Related]
64. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
65. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
Hu K; Li K; Lv J; Feng J; Chen J; Wu H; Cheng F; Jiang W; Wang J; Pei H; Chiao PJ; Cai Z; Chen Y; Liu M; Pang X
J Clin Invest; 2020 Apr; 130(4):1752-1766. PubMed ID: 31874110
[TBL] [Abstract][Full Text] [Related]
66. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma.
Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z
J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601
[TBL] [Abstract][Full Text] [Related]
67. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
[TBL] [Abstract][Full Text] [Related]
68. Expression and Prognostic Significance of Ferroptosis-related Proteins SLC7A11 and GPX4 in Renal Cell Carcinoma.
Ren Z; Zhang X; Han J
Protein Pept Lett; 2023; 30(10):868-876. PubMed ID: 37807410
[TBL] [Abstract][Full Text] [Related]
69. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis.
Zhang W; Li Q; Zhang Y; Wang Z; Yuan S; Zhang X; Zhao M; Zhuang W; Li B
Apoptosis; 2024 Apr; 29(3-4):412-423. PubMed ID: 38001343
[TBL] [Abstract][Full Text] [Related]
70. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
[TBL] [Abstract][Full Text] [Related]
71. Identification of a novel snoRNA expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on RNA sequencing dataset.
Zhang L; Xin M; Wang P
Math Biosci Eng; 2021 Sep; 18(6):7837-7860. PubMed ID: 34814278
[TBL] [Abstract][Full Text] [Related]
72. Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
Long W; Li Q; Zhang J; Xie H
Med Oncol; 2021 Jun; 38(7):83. PubMed ID: 34117948
[TBL] [Abstract][Full Text] [Related]
73. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m
Chen SJ; Zhang J; Zhou T; Rao SS; Li Q; Xiao LY; Wei ST; Zhang HF
Redox Biol; 2024 Feb; 69():102975. PubMed ID: 38042059
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
75. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
[TBL] [Abstract][Full Text] [Related]
77. Regulation of Ferroptosis in Lung Adenocarcinoma.
Wei X; Li X; Hu S; Cheng J; Cai R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834062
[TBL] [Abstract][Full Text] [Related]
78. CircSCUBE3 promoted ferroptosis to inhibit lung adenocarcinoma progression.
Fu H; Zhao Q
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):161-168. PubMed ID: 38430026
[TBL] [Abstract][Full Text] [Related]
79. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
80. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
